Lien Vo

1.2k total citations
38 papers, 966 citations indexed

About

Lien Vo is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lien Vo has authored 38 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 7 papers in Internal Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lien Vo's work include Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Arrhythmias and Treatments (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Lien Vo is often cited by papers focused on Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Arrhythmias and Treatments (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Lien Vo collaborates with scholars based in United States, Belgium and United Kingdom. Lien Vo's co-authors include Myoung Kim, Ebbing Lautenbach, Warren B. Bilker, Marie Synnestvedt, Jeff Schein, Mark G. Weiner, Susan Martin, Henry P. Parkman, Hrair P. Simonian and Robert S. Fisher and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Lien Vo

36 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lien Vo United States	15	209	199	155	152	147	38	966
Reinier M. van Hest Netherlands	24	158 0.8×	152 0.8×	249 1.6×	179 1.2×	114 0.8×	83	1.9k
Athanasios Prekates Greece	16	316 1.5×	319 1.6×	54 0.3×	119 0.8×	53 0.4×	34	1.1k
Gaëtan Plantefève France	15	180 0.9×	72 0.4×	263 1.7×	186 1.2×	35 0.2×	42	1.2k
Simon W. Lam United States	22	126 0.6×	161 0.8×	337 2.2×	132 0.9×	99 0.7×	105	1.5k
Jaya Natarajan United States	19	153 0.7×	242 1.2×	108 0.7×	47 0.3×	209 1.4×	44	1.4k
Phillip D. Levin Israel	20	331 1.6×	140 0.7×	117 0.8×	120 0.8×	203 1.4×	58	1.5k
Robert E. Ariano Canada	25	144 0.7×	359 1.8×	260 1.7×	242 1.6×	89 0.6×	74	1.9k
Styliani Lagou Greece	7	215 1.0×	179 0.9×	136 0.9×	75 0.5×	27 0.2×	10	627
Christoph Lichtenstern Germany	22	154 0.7×	93 0.5×	290 1.9×	98 0.6×	99 0.7×	91	1.6k
Pierre‐François Dequin France	23	187 0.9×	62 0.3×	150 1.0×	36 0.2×	110 0.7×	76	1.5k

Countries citing papers authored by Lien Vo

Since Specialization

Citations

This map shows the geographic impact of Lien Vo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lien Vo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lien Vo more than expected).

Fields of papers citing papers by Lien Vo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lien Vo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lien Vo. The network helps show where Lien Vo may publish in the future.

Co-authorship network of co-authors of Lien Vo

This figure shows the co-authorship network connecting the top 25 collaborators of Lien Vo. A scholar is included among the top collaborators of Lien Vo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lien Vo. Lien Vo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Girard, Nicolas, Lien Vo, Mohammad A. Chaudhary, et al.. (2024). Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers. 16(13). 2492–2492.

Provencio, Mariano, Enric Carcereny, Rafael López Castro, et al.. (2023). Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study. Translational Lung Cancer Research. 12(10). 2113–2128. 7 indexed citations

Neslusan, C., et al.. (2018). Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States. Diabetes Therapy. 9(2). 565–581. 17 indexed citations

Weycker, Derek, Xiaoyan Li, Gail Wygant, et al.. (2018). SAFETY AND EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN THE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM. Journal of the American College of Cardiology. 71(11). A1953–A1953. 1 indexed citations

Trocio, Jeffrey, Virginia M. Rosen, Anu Gupta, et al.. (2018). Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings. ClinicoEconomics and Outcomes Research. Volume 11. 23–49. 4 indexed citations

Amin, Alpesh, Allison Keshishian, Jeffrey Trocio, et al.. (2018). A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population. Journal of Managed Care & Specialty Pharmacy. 24(9). 911–920. 27 indexed citations

Amin, Alpesh, Allison Keshishian, Jeffrey Trocio, et al.. (2017). EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN, AND RIVAROXABAN COMPARED TO WARFARIN AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US MEDICARE POPULATION. Journal of the American College of Cardiology. 69(11). 316–316. 2 indexed citations

Henk, Henry J., Feng Cao, Prianka Singh, et al.. (2017). Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting. Current Medical Research and Opinion. 34(3). 539–546. 1 indexed citations

Amin, Alpesh, Allison Keshishian, Lin Xie, et al.. (2016). REAL-WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG UNTREATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS AND THOSE INITIATING APIXABAN, DABIGATRAN, RIVAROXABAN, OR WARFARIN. Journal of the American College of Cardiology. 67(13). 668–668. 2 indexed citations

10.

Trocio, Jeffrey, Amanda Bruno, Prianka Singh, et al.. (2015). Treatment and Discharge Patterns Among Patients Hospitalized With Nonvalvular Atrial Fibrillation (NVAF) Who Transition From the Inpatient to Outpatient Setting. CHEST Journal. 148(4). 66A–66A.

11.

Montejano, Leslie, Lien Vo, & Donna McMorrow. (2015). Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization. Diabetes Therapy. 7(1). 91–103. 14 indexed citations

12.

Lerner, Debra, William H. Rogers, Hong Chang, et al.. (2015). The Health Care and Productivity Costs of Back and Neck Pain in A Multi-Employer Sample of Utility Industry Employees. Journal of Occupational and Environmental Medicine. 57(1). 32–43. 9 indexed citations

13.

Tkacz, Joseph, et al.. (2013). Opioid analgesic-treated chronic pain patients at risk for problematic use.. PubMed. 19(11). 871–80. 12 indexed citations

14.

Lipsky, Benjamin A., Gregory J. Moran, Lena M. Napolitano, et al.. (2012). A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes. BMC Infectious Diseases. 12(1). 227–227. 49 indexed citations

15.

Cepeda, M. Soledad, et al.. (2012). Comparison of Opioid Doctor Shopping for Tapentadol and Oxycodone: A Cohort Study. Journal of Pain. 14(2). 158–164. 36 indexed citations

16.

Kollef, Marin H., Marya D. Zilberberg, Andrew F. Shorr, et al.. (2010). Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study. Journal of Infection. 62(2). 130–135. 75 indexed citations

17.

Lautenbach, Ebbing, Marie Synnestvedt, Mark G. Weiner, et al.. (2009). Imipenem Resistance in Pseudomonas aeruginosa Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes. Infection Control and Hospital Epidemiology. 31(1). 47–53. 95 indexed citations

18.

Lautenbach, Ebbing, Marie Synnestvedt, Mark G. Weiner, et al.. (2009). Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii. Infection Control and Hospital Epidemiology. 30(12). 1186–1192. 89 indexed citations

19.

Suh, Dong‐Churl, Simu K. Thomas, Elmira Valiyeva, Stephen Arcona, & Lien Vo. (2005). Drug Persistency of Two Cholinesterase Inhibitors. Drugs & Aging. 22(8). 695–707. 44 indexed citations

20.

Simonian, Hrair P., et al.. (2005). Regional Postprandial Differences in pH Within the Stomach and Gastroesophageal Junction. Digestive Diseases and Sciences. 50(12). 2276–2285. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact